Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-3405 in Participants With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase 1, Open-Label Study to Assess Pharmacokinetics After Single Doses of Pociredir in Participants With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-30A Pilot Study of Everyday Stress and Pain Intensity Reduction Intervention Via Tongues and Understanding Study in Adult Outpatients With Sickle Disease (ESPIRITU Study)
-
CLINICAL_TRIALS study record update · 2026-03-30Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
-
CLINICAL_TRIALS study record update · 2026-03-27Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-27Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease: Multicenter, Randomized, Double-blind, Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Frequent Vaso-Occlusive Crises
-
CLINICAL_TRIALS study record update · 2026-03-25A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects With Severe Sickle Cell Disease, βS/βC Genotype
-
CLINICAL_TRIALS study record update · 2026-03-24Revamping Exercise Assessments in Child Health (Project REACH)
-
CLINICAL_TRIALS study record update · 2026-03-24An Open-label, Multi-centre, Rollover Study to Characterise Long-term Safety and Efficacy of Etavopivat in Adults, Adolescents and Children Who Have Sickle Cell Disease or Thalassaemia and Have Completed a Treatment Period in an Etavopivat Study
-
CLINICAL_TRIALS study record update · 2026-03-23Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease (PF-Guide)
-
CLINICAL_TRIALS study record update · 2026-03-23A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-20A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Adult and Adolescent Participants With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-19Inflammation, Platelets and Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-19An Open-label Extension Study to Evaluate the Long-term Safety of GBT021601 Administered to Participants With Sickle Cell Disease Who Have Participated in a GBT021601 Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-17Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease: A Prospective, Phase II Study.
-
CLINICAL_TRIALS study record update · 2026-03-13Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
-
CLINICAL_TRIALS study record update · 2026-03-12Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase I/II Study of Nula-cel in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-10Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-10Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
-
CLINICAL_TRIALS study record update · 2026-03-09High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-03-09Double-blind, Randomized, Placebo Controlled Study to Evaluate Optimal Timing of Ketamine Initiation
-
CLINICAL_TRIALS study record update · 2026-03-09Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults: A Randomized Control Trial